AbbVie makes up about 2.6% of St. Louis Financial Planners Asset Management LLC’s investment portfolio, making the stock its 7th largest holding. Litman Gregory Wealth Management LLC purchased a new position in shares of AbbVie in the fourth quarter worth $28,000. Imprint Wealth LLC increased its holdings in AbbVie by 56.2% in the 4th quarter. Wall Street Zen downgraded AbbVie from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 5th. Two analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have assigned a Hold rating to the company’s stock.